In this guide
What is vitamin B3?
Vitamin B3 is the family name for niacin activity supplied by nicotinic acid, nicotinamide (niacinamide) and dietary tryptophan converted by the body. It supports formation of NAD and NADP, coenzymes used in energy metabolism and many cellular reactions. [1]
The label word “niacin” can hide clinically meaningful differences. A food-level intake, a modest multi-nutrient amount and a gram-dose extended-release nicotinic-acid medicine are different exposures. Read the chemical form, release pattern and amount rather than treating them as one protocol.
Typical Vitamin B3 Protocols
| Purpose or population | Form and amount each time | Frequency | Total per day | Duration |
|---|---|---|---|---|
| RDA, adult men 19+ | Niacin from all sources | Daily | 16 mg NE | Ongoing reference intake |
| RDA, adult women 19+ | Niacin from all sources | Daily | 14 mg NE | Ongoing reference intake |
| RDA, pregnancy | Niacin from all sources | Daily | 18 mg NE | During pregnancy |
| RDA, lactation | Niacin from all sources | Daily | 17 mg NE | During lactation |
| Adult U.S. UL | Supplemental and fortified nicotinic acid plus nicotinamide | Daily | 35 mg | Chronic upper boundary |
| HPS2-THRIVE, 25,673 high-risk adults after active run-in | Extended-release nicotinic acid 2 g + laropiprant 40 mg | Once daily | 2 g + 40 mg | Median 3.9 years |
The trial row is a pharmacologic combination schedule, not a wellness range. Participants were 50–80 years old, had vascular disease, and were receiving statin-based therapy. Its findings cannot isolate nicotinic acid from laropiprant and do not support self-treatment. [4]
Where these amounts come from
Nutrient, limit and drug trial
The same vitamin name can describe very different exposures.
Never collapse gram-dose drug therapy into a routine supplement range.
Does vitamin B3 need to be cycled?
No nutrition authority defines a general niacin cycle. If a clinician uses pharmacologic nicotinic acid, the product, titration, laboratory plan and review date belong to that prescription context. A trial duration is not a reason to reproduce the regimen.
What happens when niacin is stopped?
Vitamin B3 does not cause a recognized supplement withdrawal syndrome. Flushing from immediate-release nicotinic acid resolves as exposure falls. Stopping prescribed niacin can change lipid measurements, so medication changes should be coordinated with the prescriber.
Which foods provide niacin?
Poultry, beef, pork, fish, nuts, legumes and enriched or fortified grain products contribute niacin. Protein foods also provide tryptophan. One NE equals 1 mg preformed niacin or 60 mg dietary tryptophan, allowing both sources to be counted toward the requirement. [1]
Which form should a label name?
Nicotinic acid causes the characteristic warmth, redness, itching or tingling called flushing. At pharmacologic doses it can change lipids. Immediate-, sustained- and extended-release products differ in absorption and adverse-effect patterns; they should not be casually substituted. [1]
Nicotinamide, also called niacinamide, does not produce the same flushing or lipid effects, although high doses still can cause toxicity. Products promoted as “no-flush niacin” may use inositol hexanicotinate; the label should not be assumed equivalent to studied nicotinic acid. [1]
Nicotinamide riboside and nicotinamide mononucleotide are NAD precursors with separate evidence and regulatory questions. Their milligram amounts should not be interpreted through the ordinary niacin RDA or the HPS2-THRIVE regimen.
How should niacin be stored?
Use the product label for temperature, moisture and expiry. Keep the container closed, away from children, and preserve the original label so the exact form and release pattern remain identifiable.
What is vitamin B3 commonly used for?
Niacin prevents and treats deficiency, including pellagra. Supplements are also marketed for energy or skin health, but essential coenzyme function does not show that extra intake improves those outcomes in a replete person. Pharmacologic nicotinic acid has been used to change lipid measures; modern outcome evidence and adverse effects determine whether that is clinically worthwhile.
What does human research show?
HPS2-THRIVE randomized 25,673 adults aged 50–80 with atherosclerotic vascular disease after an active run-in. All received effective statin-based therapy; the intervention added extended-release nicotinic acid 2 g plus laropiprant 40 mg once daily. Over a median 3.9 years, HDL cholesterol rose and LDL cholesterol fell modestly, but major vascular events were not significantly reduced. [4]
The combination increased serious adverse events involving diabetes control, new diabetes diagnoses, gastrointestinal and musculoskeletal systems, skin, infection and bleeding. Because laropiprant was included, the report cannot attribute every harm to nicotinic acid alone. It does show why a favorable biomarker change cannot substitute for patient-important outcomes. [4]


How does vitamin B3 work?
Nicotinic acid and nicotinamide can contribute to NAD and NADP. These coenzymes transfer electrons in energy metabolism and support reactions involved in cellular signaling and repair. Nicotinic acid at pharmacologic exposure also acts through pathways that change lipoprotein metabolism. Those mechanisms do not guarantee a cardiovascular outcome. [1], [4]
What are the risks and interactions?
Nicotinic acid flushing can begin at 30–50 mg, though susceptibility varies. Larger supplemental or drug doses can cause low blood pressure, gastrointestinal symptoms, impaired glucose tolerance, gout and liver injury. Sustained-release products may cause less flushing while increasing hepatotoxicity risk. Nicotinamide generally does not flush, but gram doses can still cause nausea, vomiting and liver toxicity. [1]
The adult UL of 35 mg/day applies to niacin from supplements and fortified foods and is based on flushing. It does not apply to naturally occurring food niacin or to medically supervised use, and it is not a threshold below which every product is risk-free. [1]
In the United States, dietary supplements generally are not FDA-approved for safety or effectiveness before sale. In Canada, natural health products require a product licence and authorized labels carry an NPN or DIN-HM. [2], [3]
Which medicines and conditions matter?
High-dose nicotinic acid needs particular caution with diabetes medicines, blood-pressure medicines, anticoagulant or antiplatelet therapy and other agents that may affect the liver. Statin combinations need clinician oversight because muscle and liver risks depend on the regimen and patient. Gout, active liver disease, peptic-ulcer symptoms and substantial alcohol use should be disclosed before high-dose use. [1]
What should be monitored?
For ordinary nutrient intake, count niacin across fortified foods, multivitamins, B complexes and standalone products. If pharmacologic nicotinic acid is prescribed, monitoring can include symptoms, flushing, blood pressure, glucose control, uric acid, liver tests and the clinical reason for treatment. Exact tests and timing depend on the product and medical context. [1]
What do public communities report?
Public discussions often focus on flushing, “no-flush” labels or lipid-test changes. These reports cannot establish rates or benefits because the chemical form, release pattern, amount, concurrent medicines and diagnosis are often missing. This overhaul did not independently recrawl or quantify community posts.
How does vitamin B3 compare with nearby options?
| Guide | What it is | Key difference |
|---|---|---|
| Vitamin B2 | Riboflavin coenzyme precursor | Different intake values and no established U.S. UL |
| Vitamin B6 | Pyridoxine-family vitamin | Excess exposure is associated with sensory neuropathy |
| Nicotinamide riboside | NAD precursor | Separate human trial evidence; not a substitute for the niacin RDA |
| NMN | Nicotinamide mononucleotide | Separate evidence and evolving U.S. regulatory history |
| Women's multivitamin | Multi-nutrient product | May already contain niacin and contribute to the 35 mg UL |
Common questions about vitamin B3
Are niacin and niacinamide the same?
They both provide niacin activity, but their flushing and pharmacologic lipid effects differ. Read the specific form. [1]
What does mg NE mean?
It means milligrams of niacin equivalents. One mg NE equals 1 mg niacin or 60 mg dietary tryptophan. [1]
Does the 35 mg UL include food?
It includes supplemental niacin and niacin added to fortified foods. It excludes naturally occurring food niacin and medically supervised treatment. [1]
Does flushing mean niacin is working?
No. Flushing is a pharmacologic adverse effect, not a validated marker of benefit.
Is “no-flush niacin” equivalent to nicotinic acid?
No assumption is safe from the marketing name. Check whether the product contains niacinamide or inositol hexanicotinate and whether evidence matches that form. [1]
Did high-dose niacin prevent cardiovascular events?
In HPS2-THRIVE, extended-release nicotinic acid plus laropiprant did not significantly reduce major vascular events when added to statin-based therapy and increased serious adverse events. [4]
Can niacin affect liver tests or glucose?
Yes at high exposure. Clinician-directed gram-dose use can require liver and metabolic monitoring. [1]
Glossary
Plain explanations of niacin nutrition and trial terms.
- Niacin equivalent (NE)
- An intake unit: 1 mg NE equals 1 mg niacin or 60 mg dietary tryptophan.
- NAD
- A niacin-derived coenzyme involved in energy transfer, signaling and other cellular reactions.
- Recommended Dietary Allowance (RDA)
- A total daily intake intended to meet the needs of nearly all healthy people in a group.
- Tolerable Upper Intake Level (UL)
- A chronic intake boundary; the U.S. adult niacin UL covers supplemental and fortified sources and is based on flushing.
- Niacin flushing
- Warmth, redness, itching or tingling caused especially by nicotinic acid.
- Laropiprant
- The anti-flushing drug paired with extended-release nicotinic acid in HPS2-THRIVE, limiting attribution to niacin alone.
How this guide was researched
This draft uses the current NIH ODS niacin monograph, the primary HPS2-THRIVE report and current FDA and Health Canada regulatory pages. Relevant source text was retrieved and read on October 9, 2026.
How this guide was made
Research and drafting were AI-assisted. This draft awaits Doserly editorial and independent clinical review. Doserly makes a tracking app and operates Doserly Academy, both promoted here. Read the editorial policy.
Explore the sources
Official nutrition, primary trial and regulatory sources answer different questions.
Showing 4 sources
- 01
Niacin - Health Professional Fact Sheet ↗
Official nutrient monograph
Current relevant sections reviewed.
Detail: Identity, niacin equivalents, foods, RDAs, forms, UL scope, flushing, liver risk and interactions.
- 02
Questions and Answers on Dietary Supplements ↗
Regulatory overview
Current official page reviewed.
Detail: U.S. supplement framework.
- 03
Product Licensing ↗
Regulatory overview
Current official page reviewed.
Detail: Canadian licensing and NPN or DIN-HM.
- 04
Effects of extended-release niacin with laropiprant in high-risk patients. ↗
Randomized controlled outcome trial
Primary report abstract and bibliographic record read.
Detail: 25,673 adults age 50–80 with vascular disease; ER nicotinic acid 2 g plus laropiprant 40 mg daily versus placebo on statin-based therapy; median 3.9 years; vascular outcome and serious adverse events.
No matching sources
Try a different term or show the full list.